ecancermedicalscience

Case Report

Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

18 Oct 2012
G Masci, A Losurdo, C Gandini, I Garassino, L di Tommaso, R Torrisi, M Zuradelli, A Santoro

We report the case of a 34-year-old woman affected by breast cancer that had metastasized to the bone. She had been treated with oral cyclophosphamide and methotrexate (metronomic chemotherapy) and achieved 3.5 years of clinical remission. To our knowledge, this is the first description of such a prolonged response to therapy. This case report adds weight to known data on metronomic treatment and supports further investigation of this therapy.

Related Articles

Abhishek Sharma, Shagun Mahajan, Sanjit Kumar Agrawal, Rosina Ahmed, Debdeep Dey
Yazmín A Ramírez-Galván, Servando Cardona-Huerta, Guillermo Elizondo-Riojas, Alberto Montemayor-Martínez, Jesús I Morales-Escajeda, Carlos E Herrera-Peña
Aragaw Tesfaw, Hanna Berihun, Eshetie Molla, Gashaw Mihret, Dejen Getaneh Feleke, Ermias Sisay Chanie, Biruk Demissie, Tewodros Yosef, Abel Shita, Fitalew Tadele, Efrem Fenta
Isália Miguel, Fátima Rodrigues, Sofia Fragoso, João Freixo, Ana Clara, Ana Luis, Sandra Bento, Mariana Fernandes, Filipe Bacelar, Sara Câmara, Joana Parreira, Teresa Duarte, Paula Rodrigues, Sidónia Santos, Fátima Vaz
Sergio Nascimento, Rosemar Macedo Sousa Rahal, Leonardo Ribeiro Soares, Herik Jansen de Souza Pimentel, Tágara Oliveira Kamimura, Ruffo Freitas-Junior
Mayra de Carmen Ortega Jiménez, Deysi Emilia García Rodríguez, Brenda Hidalgo Mares, Marcela Ortega Jiménez